[Federal Register Volume 75, Number 45 (Tuesday, March 9, 2010)]
[Notices]
[Pages 10803-10805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4885]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-10-09AM]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to [email protected]. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-5806. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Prevalence Survey of Healthcare Associated Infections (HAIs) and

[[Page 10804]]

Antimicrobial Use in U.S. Acute Care Hospitals--New--National Center 
for Emerging and Zoonotic Infectious Diseases (NCEZID) (proposed), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting OMB approval to conduct two surveys to obtain 
national estimates of HAI prevalence and antimicrobial use in the 
United States. Preventing HAIs is a CDC priority, and an essential step 
in reducing the occurrence of HAIs is to accurately estimate the burden 
of these infections in U.S. hospitals and to describe the types of HAIs 
and their causative organisms, including antimicrobial-resistant 
pathogens.
    The scope and magnitude of HAIs in the U.S. were last directly 
estimated in the 1970s and 1980s by CDC's Study on the Efficacy of 
Nosocomial Infection Control (SENIC), in which comprehensive data were 
collected from a sample of 338 hospitals; 5% of hospitalized patients 
acquired an infection not present at the time of admission. CDC's 
current HAI surveillance system, the National Healthcare Safety Network 
(NHSN) (OMB Control No. 0920-0666, expiration date 9/30/2012), focuses 
instead on device-associated and procedure-associated infections in a 
variety of patient locations, and does not receive data on all types of 
HAIs to make hospital-wide burden estimates. The purpose of this 
information collection request is to assess the magnitude and types of 
HAIs and antimicrobial use occurring in all patient populations within 
acute care hospitals. This information will be used to inform decisions 
made by local and national policy makers and hospital infection control 
personnel regarding appropriate targets and strategies for preventing 
HAIs and the emergence of antimicrobial-resistant pathogens and 
encouraging appropriate antimicrobial use. Such assessments can be 
obtained in periodic national prevalence studies, such as those that 
have been conducted in several European countries.
    CDC proposes to conduct two surveys to collect this data. The first 
survey will be a limited roll-out survey and will be conducted in 30 
facilities across 10 states in collaboration with state public health 
authorities and CDC's Emerging Infections Program (EIP). The survey 
will be conducted on a single day in participating facilities. 
Infection Control Practitioners in participating facilities, such as 
infection control personnel, will collect limited demographic and 
clinical information on a sample of eligible inpatients and, on the 
same day, EIP site personnel will collect information on HAIs and 
antimicrobial use for surveyed patients who are on antimicrobial 
therapy at the time of the survey. The second survey will involve 500 
facilities across the same 10 states and use the same methodology. As 
with the first survey, CDC will collaborate with state public health 
authorities and EIP sites.
    CDC has made the following assumptions in calculating the response 
burden. Infection Control Practitioners will be asked to collect a 
minimal amount of data, limited to basic demographic and risk factor/
antimicrobial use information. We anticipate that this data collection 
will take 5 minutes per patient. EIP personnel will complete data 
collection on antimicrobial use and HAIs. CDC estimates that this data 
collection will take approximately 15 minutes per patient.
    CDC has assumed an average daily patient census of 250 patients for 
each of the 30 participating facilities in Survey 1. An 
Infection Control Practitioner (ICP) in his/her own facility will be 
asked to review \1/3\ or 33% of this number (250); thus, the ICP would 
review 82.5 records (rounded up to 83). This number is estimated to be 
the same in each phase of the prevalence survey effort.
    EIP Personnel will be reviewing medical records of approximately 
40% of all patients surveyed in their EIP site in both surveys 
1 and 2. In Survey 1, the total number of 
patient records surveyed in each EIP site (assuming 3 facilities in 
each EIP site and 83 patient records per site) is 247.5 patient 
records. Forty percent of that number (247.5) is 99 patient records or 
99 responses per EIP site. In Survey 2, there will be more 
facilities participating per EIP site (50 facilities per EIP site for a 
total of 500 facilities). Again, CDC assumes 82.5 records surveyed per 
site (50 x 82.5) or a total of 4,125 patient records. As above, EIP 
personnel in each of the 10 sites will review approximately 40% of the 
4,125 patient records per site or 1,650 patient records.
    CDC will use the data provided to estimate the prevalence of HAIs 
and antimicrobial use across this sample of U.S. hospitals as well as 
to estimate the distribution of infection types, causative organisms, 
and nature of and rationale for antimicrobial use.
    This proposed project supports CDC's Strategic Goal of ``Healthy 
Healthcare Settings,'' specifically the objectives to ``Promote 
compliance with evidence-based guidelines for preventing, identifying, 
and managing disease in healthcare settings'' and ``Prevent adverse 
events in patients and healthcare workers in healthcare settings.''
    There are no costs to respondents, other than their time to 
complete the survey. The total annualized burden for this data 
collection is 8,039 hours.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
                           Respondents                               Number of     responses per   per  response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Infection Control Practitioners--Survey 1..............              30              83            5/60
EIP Personnel--Survey 1................................              10              99           15/60
Infection Control Practitioners--Survey 2..............             500              83            5/60
EIP Personnel--Survey 2................................              10           1,650           15/60
----------------------------------------------------------------------------------------------------------------



[[Page 10805]]

    Dated: February 26, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-4885 Filed 3-8-10; 8:45 am]
BILLING CODE 4163-18-P